Literature DB >> 28560931

Psychosis and dementia: risk factor, prodrome, or cause?

Corinne E Fischer1, Luis Agüera-Ortiz2.   

Abstract

BACKGROUND: Progression of dementia is often associated with the emergence of neuropsychiatric symptoms (NPS), though there is recent evidence that NPS may occur in prodromal dementia (PrD) and impact clinical course. Mood and anxiety symptoms are the NPS that tend to occur most frequently in PrD and thus have been most extensively studied. Comparatively, there has been little focus on psychotic symptoms in PrD.
METHODS: The authors review the existing literature on psychosis in PrD, including the functional psychosis of early and late onset, with a focus on epidemiology, phenomenology, and clinical course and treatment considerations.
RESULTS: Patients with psychotic disorders at baseline such as schizophrenia may be more at risk for developing dementia over time, although this is not completely clear. Psychotic symptoms are likely more common in PrD than previously understood based on factor analysis studies, although they are much more common in established dementia. Variability in findings may reflect the heterogeneous nature of PrD studies to date and the lack of inclusion of patients with late onset psychosis in most clinical studies. The presence of psychosis in patients with PrD may be associated with a worse prognosis in terms of mortality and conversion to dementia.
CONCLUSIONS: Research to date suggests that psychosis in PrD may be more common than previously thought and impact clinical course negatively. Future studies incorporating patients with late onset psychotic disorders, and focusing on the impact of early recognition and treatment, are required to more fully understand the role of psychosis in PrD.

Entities:  

Keywords:  Alzheimer's disease; delusions; dementia; hallucinations; mild behavioral impairment; mild cognitive impairment; psychosis

Mesh:

Year:  2017        PMID: 28560931     DOI: 10.1017/S1041610217000874

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  11 in total

1.  Assessment of 3-dimensional wisdom in schizophrenia: Associations with neuropsychological functions and physical and mental health.

Authors:  Ryan Van Patten; Ellen E Lee; Rebecca Daly; Elizabeth Twamley; Xin M Tu; Dilip V Jeste
Journal:  Schizophr Res       Date:  2019-02-14       Impact factor: 4.939

Review 2.  Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.

Authors:  Zahinoor Ismail; Byron Creese; Dag Aarsland; Helen C Kales; Constantine G Lyketsos; Robert A Sweet; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2022-01-04       Impact factor: 44.711

3.  Delusional Severity Is Associated with Abnormal Texture in FLAIR MRI.

Authors:  Marc A Khoury; Mohamad-Ali Bahsoun; Ayad Fadhel; Shukrullah Shunbuli; Saanika Venkatesh; Abdollah Ghazvanchahi; Samir Mitha; Karissa Chan; Luis R Fornazzari; Nathan W Churchill; Zahinoor Ismail; David G Munoz; Tom A Schweizer; Alan R Moody; Corinne E Fischer; April Khademi
Journal:  Brain Sci       Date:  2022-05-05

4.  Plasma Neurofilament Light: A Marker of Neurodegeneration in Mild Behavioral Impairment.

Authors:  James P Naude; Sascha Gill; Sophie Hu; Alexander McGirr; Nils D Forkert; Oury Monchi; Peter K Stys; Eric E Smith; Zahinoor Ismail
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort.

Authors:  Veronika Matuskova; Zahinoor Ismail; Tomas Nikolai; Hana Markova; Katerina Cechova; Zuzana Nedelska; Jan Laczó; Meng Wang; Jakub Hort; Martin Vyhnalek
Journal:  Front Aging Neurosci       Date:  2021-05-24       Impact factor: 5.750

6.  Psychotropic Medication Use Is Associated With Greater 1-Year Incidence of Dementia After COVID-19 Hospitalization.

Authors:  Yun Freudenberg-Hua; Alexander Makhnevich; Wentian Li; Yan Liu; Michael Qiu; Allison Marziliano; Maria Carney; Blaine Greenwald; John M Kane; Michael Diefenbach; Edith Burns; Jeremy Koppel; Liron Sinvani
Journal:  Front Med (Lausanne)       Date:  2022-03-18

7.  Association between anticholinergic burden and dementia in UK Biobank.

Authors:  Jure Mur; Tom C Russ; Simon R Cox; Riccardo E Marioni; Graciela Muniz-Terrera
Journal:  Alzheimers Dement (N Y)       Date:  2022-04-12

Review 8.  Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.

Authors:  Luis Agüera-Ortiz; Ganesh M Babulal; Marie-Andrée Bruneau; Byron Creese; Fabrizia D'Antonio; Corinne E Fischer; Jennifer R Gatchel; Zahinoor Ismail; Sanjeev Kumar; William J McGeown; Moyra E Mortby; Nicolas A Nuñez; Fabricio F de Oliveira; Arturo X Pereiro; Ramit Ravona-Springer; Hillary J Rouse; Huali Wang; Krista L Lanctôt
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

9.  Factors associated with late-life psychosis in primary care older adults without a diagnosis of dementia.

Authors:  Helen-Maria Vasiliadis; Isabelle Pitrou; Catherine Lamoureux-Lamarche; Sébastien Grenier; Patrick Viet-Quoc Nguyen; Carol Hudon
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-07-05       Impact factor: 4.328

Review 10.  Psychosis in Alzheimer's Disease.

Authors:  Clive Ballard; Helen C Kales; Constantine Lyketsos; Dag Aarsland; Byron Creese; Roger Mills; Hilde Williams; Robert A Sweet
Journal:  Curr Neurol Neurosci Rep       Date:  2020-10-13       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.